Atea Pharmaceuticals Inc (AVIR)
3.24
+0.08
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
3.24
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Price to Book Value: 0.5968 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 0.5821 |
November 19, 2024 | 0.5784 |
November 18, 2024 | 0.5839 |
November 15, 2024 | 0.5931 |
November 14, 2024 | 0.6097 |
November 13, 2024 | 0.6171 |
November 12, 2024 | 0.6134 |
November 11, 2024 | 0.6189 |
November 08, 2024 | 0.6447 |
November 07, 2024 | 0.6337 |
November 06, 2024 | 0.6595 |
November 05, 2024 | 0.6189 |
November 04, 2024 | 0.6171 |
November 01, 2024 | 0.606 |
October 31, 2024 | 0.5968 |
October 30, 2024 | 0.6042 |
October 29, 2024 | 0.6245 |
October 28, 2024 | 0.63 |
October 25, 2024 | 0.6171 |
October 24, 2024 | 0.6226 |
October 23, 2024 | 0.641 |
October 22, 2024 | 0.6558 |
October 21, 2024 | 0.6613 |
October 18, 2024 | 0.7037 |
October 17, 2024 | 0.6871 |
Date | Value |
---|---|
October 16, 2024 | 0.6945 |
October 15, 2024 | 0.6539 |
October 14, 2024 | 0.6503 |
October 11, 2024 | 0.641 |
October 10, 2024 | 0.6153 |
October 09, 2024 | 0.6263 |
October 08, 2024 | 0.6281 |
October 07, 2024 | 0.6281 |
October 04, 2024 | 0.6374 |
October 03, 2024 | 0.6134 |
October 02, 2024 | 0.6208 |
October 01, 2024 | 0.6134 |
September 30, 2024 | 0.6171 |
September 27, 2024 | 0.6095 |
September 26, 2024 | 0.6095 |
September 25, 2024 | 0.6077 |
September 24, 2024 | 0.6201 |
September 23, 2024 | 0.6113 |
September 20, 2024 | 0.6503 |
September 19, 2024 | 0.6768 |
September 18, 2024 | 0.707 |
September 17, 2024 | 0.7123 |
September 16, 2024 | 0.6892 |
September 13, 2024 | 0.6857 |
September 12, 2024 | 0.6503 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3903
Minimum
Mar 24 2023
13.31
Maximum
Feb 08 2021
1.781
Average
0.668
Median
Price to Book Value Benchmarks
McKesson Corp | -- |
Pfizer Inc | 1.543 |
Doximity Inc | 9.319 |
Immuneering Corp | 1.135 |
CEL-SCI Corp | 4.372 |
Price to Book Value Related Metrics
PS Ratio | 0.7746 |
Price | 3.24 |
Earnings Yield | -63.89% |
Market Cap | 273.66M |
Operating PE Ratio | 1.967 |
Normalized PE Ratio | 2.382 |